Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Daiichi Sankyo
Cerilliant
Baxter
Cipla
McKinsey
Moodys
AstraZeneca
Colorcon
US Department of Justice

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,476,689

« Back to Dashboard

Summary for Patent: 7,476,689
Title:Therapeutic compositions for intranasal administration which include KETOROLAC
Abstract:An analgesic/anti-inflammatory pharmaceutical dosage form which comprises an effective amount of an active ingredient selected from the group consisting of racemic 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, optically active forms thereof and pharmaceutically acceptable salts thereof, in combination with a pharmaceutically acceptable excipient or diluent, said dosage form being an intranasally administrable dosage form.
Inventor(s): Santus; Giancarlo (Milan, IT), Bottoni; Giuseppe (Bergamo, IT), Bilato; Ettore (Padova, IT)
Assignee: Recordati Ireland Limited (IE)
Application Number:10/792,457
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Compound; Dosage form;

Drugs Protected by US Patent 7,476,689

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,476,689

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
ItalyMI91A2024Jul 22, 1991

International Patents Family Members for US Patent 7,476,689

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 130758 ➤ Subscribe
Germany 69206345 ➤ Subscribe
Denmark 0524587 ➤ Subscribe
European Patent Office 0524587 ➤ Subscribe
Spain 2082288 ➤ Subscribe
Greece 3019012 ➤ Subscribe
Italy MI912024 ➤ Subscribe
Italy 1250691 ➤ Subscribe
Japan H05194215 ➤ Subscribe
Japan 3586735 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
US Department of Justice
UBS
McKesson
Argus Health
AstraZeneca
Cipla
Daiichi Sankyo
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot